CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV) announced today that Martin J. Driscoll, Chief Executive Officer, Dr. Daniel B. Carr, Chief Medical Officer and President and Stephen J. Tulipano, CPA, Chief Financial Officer, will host a conference call to discuss the Company's quarterly financial condition, results of operations and key Company activities for the period ending June 30, 2009. The call will be held Tuesday, August 11th at 8:30am EDT.
